Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C, Nicolle R, Raffenne J, Tijeras-Raballand A, Brunel A, Astorgues-Xerri L, Vacher S, Arbateraz F, Fanjul M, Hilmi M, Samain R, Klein C, Perraud A, Rebours V, Mathonnet M, Bièche I, Kocher H, Cros J, Bousquet C. Neuzillet C, et al. Among authors: rebours v. J Pathol. 2022 Dec;258(4):408-425. doi: 10.1002/path.6011. Epub 2022 Oct 21. J Pathol. 2022. PMID: 36102377 Free PMC article.
Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers.
de Mestier L, Danset JB, Neuzillet C, Rebours V, Cros J, Soufir N, Hammel P. de Mestier L, et al. Among authors: rebours v. Endocr Relat Cancer. 2016 Oct;23(10):T57-67. doi: 10.1530/ERC-16-0269. Epub 2016 Aug 10. Endocr Relat Cancer. 2016. PMID: 27511924 Review.
Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas.
Robles EP, Maire F, Cros J, Vullierme MP, Rebours V, Sauvanet A, Aubert A, Dokmak S, Lévy P, Ruszniewski P. Robles EP, et al. Among authors: rebours v. United European Gastroenterol J. 2016 Aug;4(4):580-6. doi: 10.1177/2050640615623370. Epub 2016 Jan 6. United European Gastroenterol J. 2016. PMID: 27536368 Free PMC article.
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma.
Dayot S, Speisky D, Couvelard A, Bourgoin P, Gratio V, Cros J, Rebours V, Sauvanet A, Bedossa P, Paradis V, Ruszniewski P, Couvineau A, Voisin T. Dayot S, et al. Among authors: rebours v. Oncotarget. 2018 Jan 9;9(6):6952-6967. doi: 10.18632/oncotarget.24084. eCollection 2018 Jan 23. Oncotarget. 2018. PMID: 29467942 Free PMC article.
Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score.
de Mestier L, Muller M, Cros J, Vullierme MP, Vernerey D, Maire F, Dokmak S, Rebours V, Sauvanet A, Lévy P, Hammel P. de Mestier L, et al. Among authors: rebours v. United European Gastroenterol J. 2019 Apr;7(3):358-368. doi: 10.1177/2050640618824910. Epub 2019 Jan 12. United European Gastroenterol J. 2019. PMID: 31019704 Free PMC article.
Critical appraisal of MGMT in digestive NET treated with alkylating agents.
de Mestier L, Couvelard A, Blazevic A, Hentic O, de Herder WW, Rebours V, Paradis V, Ruszniewski P, Hofland LJ, Cros J. de Mestier L, et al. Among authors: rebours v. Endocr Relat Cancer. 2020 Oct;27(10):R391-R405. doi: 10.1530/ERC-20-0227. Endocr Relat Cancer. 2020. PMID: 32698158 Review.
190 results